Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of chemotherapy"
DOI: 10.1080/1120009x.2022.2149186
Abstract: The aim of the study was to evaluate clinical and microbiological efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant K. pneumoniae infections. All adult inpatients receiving 48 h of intravenous fosfomycin, alone or…
read more here.
Keywords:
intravenous fosfomycin;
carbapenem resistant;
safety;
treatment carbapenem ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Expert Review of Anti-infective Therapy"
DOI: 10.1080/14787210.2019.1573669
Abstract: ABSTRACT Introduction: The intravenous (IV) formulation of fosfomycin has been re-introduced in clinical practice mainly to overcome treatment failures against multidrug-resistant (MDR) bacteria. Appropriate dosing schedules of the IV formulation have not yet been established.…
read more here.
Keywords:
treatment;
dosing regimens;
treatment multidrug;
multidrug resistant ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofx163.1375
Abstract: Keith S. Kaye, MD, MPH1, Louis B. Rice, MD, FIDSA2, Aaron Dane, PhD3, Viktor Stus, MD, PhD4, Olexsiy Sagan, MD5, Elena Fedosiuk, MD6, Anita Das, PhD7, David Skarinsky, BS8, Paul B Eckburg, MD8 and Evelyn…
read more here.
Keywords:
urinary tract;
intravenous fosfomycin;
complicated urinary;
fosfomycin zti ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of infection in developing countries"
DOI: 10.3855/jidc.14125
Abstract: INTRODUCTION Fosfomycin has re-emerged as a possible therapeutic alternative for the treatment of resistant bacterial pathogens. Its main mechanism of action is the inhibition of the initial step of cell wall synthesis and is active…
read more here.
Keywords:
drug resistant;
resistant infections;
multi drug;
hospital lebanon ... See more keywords